• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植受者晚期移植物失功:发生率、危险因素和临床结局。

Late graft failure in heart transplant recipients: incidence, risk factors and clinical outcomes.

机构信息

Servicio de Cardiología.

Servicio de Medicina Intensiva.

出版信息

Eur J Heart Fail. 2018 Feb;20(2):385-394. doi: 10.1002/ejhf.886. Epub 2017 Jun 5.

DOI:10.1002/ejhf.886
PMID:28580728
Abstract

AIM

To analyse the incidence, risk factors and clinical outcomes of late graft failure after heart transplantation.

METHODS AND RESULTS

We conducted an observational, single-centre study based on 547 patients who underwent cardiac transplantation from 1991 to 2014 and who survived the in-hospital postoperative period. Late graft failure was defined as the first hospitalization due to this condition after discharge. Over a mean follow-up of 8.4 ± 6 years, 178 (32.5%) patients were hospitalized due to late graft failure [incidence rate: 3.6 cases per 100 patient-years, 95% confidence interval (CI) 3.1-4.2]. Pre-transplant diabetes, higher pre-transplant transpulmonary pressure gradient and lower donor-recipient weight ratio were independently associated with higher risk of graft failure. Cardiac allograft vasculopathy, cellular rejection grade ≥1R, and antibody-mediated rejection grade ≥1 were detected in 50.6%, 44.9% and 19.2% patients, respectively, admitted due to graft failure. Left ventricular ejection fraction was ≥50% in 60.1% of these patients. Re-transplant free survival 1, 5, 10 and 15 years after the diagnosis of late graft failure was 72.2%, 38.4%, 18.4%, and 7.5%, respectively; the incidence rate of re-hospitalization due to decompensated heart failure was 40.9 episodes per 100 patient-years (95% CI 36.6-46.1). The need for inotropes, the presence of cardiac allograft vasculopathy, higher creatinine serum levels, lower ejection fraction and lower sodium serum levels were independent predictors of worse outcomes.

CONCLUSIONS

Late graft failure is frequent after heart transplantation, as it is associated with poor outcomes. Rejection and cardiac allograft vasculopathy are the most frequent underlying causes.

摘要

目的

分析心脏移植后晚期移植物失功的发生率、危险因素和临床转归。

方法和结果

我们进行了一项观察性、单中心研究,纳入了 1991 年至 2014 年期间接受心脏移植且术后住院期间存活的 547 例患者。晚期移植物失功定义为出院后首次因该情况住院。在平均 8.4±6 年的随访中,178 例(32.5%)患者因晚期移植物失功住院[发生率:每 100 患者年 3.6 例,95%置信区间(CI)3.1-4.2]。移植前糖尿病、较高的跨肺压梯度和较低的供受者体重比与移植物失功风险增加独立相关。因移植物失功住院的患者中,分别有 50.6%、44.9%和 19.2%检测到心脏移植物血管病、细胞性排斥反应≥1R 级和抗体介导的排斥反应≥1R 级。这些患者中,左心室射血分数≥50%的比例为 60.1%。晚期移植物失功诊断后 1、5、10 和 15 年的再次移植无失功生存率分别为 72.2%、38.4%、18.4%和 7.5%;因心力衰竭失代偿而再住院的发生率为每 100 患者年 40.9 例(95%CI 36.6-46.1)。需要使用正性肌力药、存在心脏移植物血管病、较高的血肌酐水平、较低的射血分数和较低的血钠水平是预后不良的独立预测因素。

结论

心脏移植后晚期移植物失功较为常见,与不良结局相关。排斥反应和心脏移植物血管病是最常见的潜在原因。

相似文献

1
Late graft failure in heart transplant recipients: incidence, risk factors and clinical outcomes.心脏移植受者晚期移植物失功:发生率、危险因素和临床结局。
Eur J Heart Fail. 2018 Feb;20(2):385-394. doi: 10.1002/ejhf.886. Epub 2017 Jun 5.
2
Elevated Heart Rate Following Heart Transplantation Is Associated With Increased Graft Vasculopathy and Mortality.心脏移植后心率升高与移植物血管病和死亡率增加相关。
J Card Fail. 2019 Apr;25(4):249-256. doi: 10.1016/j.cardfail.2019.01.009. Epub 2019 Jan 24.
3
Impact of donor age on cardiac transplantation outcomes and on cardiac function.供体年龄对心脏移植结局及心脏功能的影响。
Interact Cardiovasc Thorac Surg. 2016 Oct;23(4):580-3. doi: 10.1093/icvts/ivw172. Epub 2016 May 31.
4
Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation.心脏移植后 30 多年心脏移植后心脏移植物血管病结局的变化。
JACC Heart Fail. 2017 Dec;5(12):891-901. doi: 10.1016/j.jchf.2017.09.014.
5
Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy.心脏移植术后晚期抗体介导的排斥反应:死亡率、移植物功能及暴发性心脏移植血管病变
J Heart Lung Transplant. 2015 Aug;34(8):1050-7. doi: 10.1016/j.healun.2015.03.002. Epub 2015 Mar 20.
6
Normothermic ex vivo allograft blood perfusion in clinical heart transplantation.临床心脏移植中的常温离体同种异体血液灌注
Heart Surg Forum. 2014 Jun;17(3):E141-5. doi: 10.1532/HSF98.2014332.
7
Cardiac allograft vasculopathy and graft failure in pediatric heart transplant recipients after rejection with severe hemodynamic compromise.在排斥反应伴有严重血流动力学障碍的儿科心脏移植受者中,心脏同种异体移植血管病和移植物衰竭。
J Heart Lung Transplant. 2019 Mar;38(3):277-284. doi: 10.1016/j.healun.2018.12.011. Epub 2018 Dec 21.
8
Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients.粒细胞集落刺激因子治疗与心脏移植受者急性排斥反应发作或移植血管病变的发生率降低有关。
Transplant Proc. 2013 Jul-Aug;45(6):2406-9. doi: 10.1016/j.transproceed.2013.01.106.
9
Dual-organ transplantation in older recipients: outcomes after heart-kidney transplant versus isolated heart transplant in patients aged ≥65 years.老年受者的双器官移植:≥65岁患者心脏-肾脏移植与单纯心脏移植后的结局
Interact Cardiovasc Thorac Surg. 2019 Jan 1;28(1):45-51. doi: 10.1093/icvts/ivy202.
10
Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.受体年龄与心脏移植死亡原因的关联:对移植后管理个体化的启示——国际心肺移植学会注册中心的分析。
J Heart Lung Transplant. 2017 Apr;36(4):407-417. doi: 10.1016/j.healun.2016.08.008. Epub 2016 Aug 20.

引用本文的文献

1
Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study.接受造血细胞移植的实体器官移植受者发生实体器官移植失败和死亡的危险因素:一项国际血液和骨髓移植研究中心(CIBMTR)与器官获取与移植网络(OPTN)的回顾性研究。
Transplantation. 2025 Jun 23. doi: 10.1097/TP.0000000000005377.
2
Cardiac allograft vasculopathy mediates the relationship between vitamin D deficiency and cardiovascular mortality following heart transplantation.心脏移植术后,心脏移植血管病变介导了维生素D缺乏与心血管死亡率之间的关系。
Am Heart J. 2025 Nov;289:138-146. doi: 10.1016/j.ahj.2025.05.008. Epub 2025 May 16.
3
Impact of Left Ventricular-Vascular Interaction on Long-Term Outcome After Heart Transplantation.左心室-血管相互作用对心脏移植术后长期预后的影响
Clin Transplant. 2025 May;39(5):e70178. doi: 10.1111/ctr.70178.
4
Sodium-glucose co-transporter 2 inhibitors in left ventricular assist device and heart transplant recipients: a mini-review.左心室辅助装置和心脏移植受者中的钠-葡萄糖协同转运蛋白2抑制剂:一篇综述
Heart Fail Rev. 2025 Mar;30(2):327-335. doi: 10.1007/s10741-024-10465-z. Epub 2024 Nov 8.
5
Intra-operative Risk Factors Affecting Mortality after Heart Transplantation: A Referral Center Experience in Iran.心脏移植术后死亡率的术中相关危险因素:伊朗转诊中心的经验。
Iran J Med Sci. 2024 Jun 1;49(6):359-368. doi: 10.30476/ijms.2023.99165.3122. eCollection 2024 Jun.
6
De Novo Donor-Specific Antibodies after Heart Transplantation: A Comprehensive Guide for Clinicians.心脏移植术后新发供者特异性抗体:临床医生综合指南
J Clin Med. 2023 Dec 2;12(23):7474. doi: 10.3390/jcm12237474.
7
Single-cell analysis of graft-infiltrating host cells identifies caspase-1 as a potential therapeutic target for heart transplant rejection.单细胞分析移植浸润宿主细胞鉴定半胱天冬酶-1 为心脏移植排斥的潜在治疗靶点。
Front Immunol. 2023 Sep 13;14:1251028. doi: 10.3389/fimmu.2023.1251028. eCollection 2023.
8
Sex differences in clinical characteristics and outcomes in patients undergoing heart transplantation.心脏移植患者的临床特征和结局的性别差异。
ESC Heart Fail. 2023 Aug;10(4):2596-2606. doi: 10.1002/ehf2.14413. Epub 2023 Jun 20.
9
Biventricular assist devices and total artificial heart: Strategies and outcomes.双心室辅助装置和全人工心脏:策略与结果。
Front Cardiovasc Med. 2023 Jan 6;9:972132. doi: 10.3389/fcvm.2022.972132. eCollection 2022.
10
Posttransplant Complications and Genetic Loci Involved in Telomere Maintenance in Heart Transplant Patients.心脏移植患者移植后并发症及与端粒维持相关的遗传位点。
Genes (Basel). 2022 Oct 14;13(10):1855. doi: 10.3390/genes13101855.